Merck KGaA's MS Drug Mavenclad May Defy Doubters

 
• By Kevin Grogan
  
Man with backpack flies behind a moving train
Not too late: Merck KGaA's new MS drug can still find a place in the market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip